Trial intelligence / Profile preview

Midazolam and ketamine prophylaxis for prevention of shivering during spinal anesthesia

IRCT20160307026950N8Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of midazolam, ketamine and Normal Saline-Benha University in postanesthetic shivering (PAS) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Shivering. Started Jun 2017; status: completed.

02

Drugs

midazolamketamineNormal Saline-Benha University
03

Conditions

postanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT20160307026950N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160307026950N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call